Journal of Hypertension · 2002 · 18 citations · 38 references
MedicinePharmacologyPhysiologyBiochemical PharmacologyMolecular PharmacologySignal TransductionBlood Pressure RegulationCardiovascular PharmacologyCardiovascular Physiology5-Lipoxygenase ActivationCysteinyl Leukotriene PathwayLeukotriene PharmacologyLeukotriene SignalingLipoxygenase InhibitionLipoxygenase Pathway
OBJECTIVES: We have previously reported that 5-lipoxygenase-derived products, and particularly the cysteinyl leukotrienes (CysLTs), were involved in angiotensin II (Ang II)-induced contractions in isolated aortas from spontaneously hypertensive rats. DESIGN: The aim of this study was to assess the role of CysLTs in the vascular response to Ang II in an Ang II-dependent model of hypertension, the (mRen-2)27 transgenic rats (TGs). METHODS: Intact aortic rings from TG and normotensive Sprague-Dawley rats (SDs) were suspended in organ chambers for isometric tension development in response to Ang II. In addition, the release of CysLTs in response to Ang II (0.3 micromol/l) was measured by enzyme immunoassay. RESULTS: In isolated aortas from TG rats, pretreatment with the 5-lipoxygenase inhibitor (AA861, 10 micromol/l) or the CysLT1 receptor antagonist (MK571, 1 micromol/l) significantly (P < 0.05) reduced Ang II-induced contractions by 52 and 42%, respectively. In addition, Ang II induced a 2.6-fold increase in CysLT release (pg/mg dry weight tissue: 58.3 +/- 17.9 (Ang II, n = 7) versus 22.5 +/- 5.9 (basal, n = 7) P < 0.05), which was inhibited by the AT1 receptor antagonist losartan (1 micromol/l). In contrast, in aortas from SD rats, pretreatment with AA861 or MK571 did not alter Ang II-induced contraction and CysLT production remained unchanged after exposure to Ang II. CONCLUSION: These data suggest that CysLTs are involved in the contractile responses to Ang II in isolated aortas from TG but not from SD rats.
38
Characterization of the human cysteinyl leukotriene CysLT1 receptor
Kevin R. Lynch, Gary P. O’Neill, Qingyun Liu et al. · Nature · 1999 · 971 citations
Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene
John J. Mullins, Jörg Peters, Detlev Ganten · Nature · 1990 · 917 citations
Life Sciences, Genetics, Physiology +16
Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis
Richard A. F. Dixon, Ronald E. Diehl, Evan E. Opas et al. · Nature · 1990 · 776 citations